GLP-1 Receptor Agonists Market
GLP-1 Receptor Agonists Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
GLP-1 Receptor Agonists Market Size and Growth
The GLP-1 receptor agonists market is experiencing significant growth, driven by increasing diabetes prevalence and obesity rates. The global market size was valued at approximately $9 billion in 2023, with projections suggesting it could surpass $20 billion by 2030. Enhanced therapeutic efficacy and expanded indications contribute to this upward trend. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ GSK
◍ Novo Nordisk
◍ Lily
◍ Haosoh
◍ Sanofi
◍ AstraZeneca
The GLP-1 receptor agonists market features major players like Novo Nordisk, Eli Lilly, AstraZeneca, Sanofi, GSK, and Haosoh. These companies innovate and enhance product offerings, driving market growth. Key sales figures include Eli Lilly’s $3.4 billion in 2022 and Novo Nordisk's significant revenue from Ozempic and Wegovy. Request Sample Report
Market Segmentation
By Application
Solid Tumors
Blood-related Tumors
Request Sample Report
By Product
Exenatide
Liraglutide
Lixisenatide
Albiglutide
Others
Market Growth
Request Sample Report
$ X Billion USD
